CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
TORONTO, Oct. 30, 2025 /CNW/ - Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance ...
The X-59 successfully completed its inaugural flight—a step toward developing quieter supersonic jets that could one day fly ...
Q2 2026 Earnings Call Transcript October 27, 2025 Operator: Greetings, and welcome to the SIFI Technologies Financial Results ...
The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...
Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...
Successful start to the conference “AI in Photonics – Adding Value in Laser Manufacturing Technology & Optical Design on October 1, 2025, in Berlin.
Vietnam Investment Review on MSN
Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
If you look at the moving pieces of working capital, receivables very much in line. Normally in Q3, you see a typical seasonal impact of a few days more DSO. Usually, year-end is always the best. So ...
The revised Law on Criminal Execution stipulates that prisoners have the right to donate tissue and body parts and to store ...
Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback